Verdict
Ghani Chemical Industries Limited (GCIL) closed FY2026 with a materially stronger earnings profile. On a consolidated basis, net sales rose 11.4% to PKR 8.28 billion, gross profit increased 29.6% to PKR 4.42 billion, and profit after tax advanced 44.1% to PKR 2.87 billion. The central improvement was a richer, higher-margin mix led by industrial and medical gases: cost of sales fell even as revenue grew, lifting the gross margin by about 7.5 percentage points.
The result is not uniformly clean. Operating cash flow fell to PKR 406 million because receivables and related-party advances absorbed cash; distribution expense almost tripled; finance cost increased 25%; and the effective tax charge was unusually low. GCIL also ended the year with higher borrowings and no dividend. The earnings improvement is real, but cash conversion and capital allocation now deserve as much attention as the income statement.
Reporting basis and comparability
This analysis uses GCIL’s consolidated audited accounts for the year ended June 30, 2026, presented in PKR thousands. The FY2025 comparison was restated after the constitutional court decision on super tax; the restatement reduced the prior-year EPS comparison from PKR 3.92 to PKR 3.88. Using the restated numbers is essential for a like-for-like comparison.
The directors’ report highlights the standalone result—PAT of PKR 2.861 billion and EPS of PKR 5.02—while the consolidated statements report PAT of PKR 2.869 billion and EPS of PKR 5.03. The small difference reflects group-level items, including share of profit from an associate and a minor discontinued-operation loss. All headline figures below use the consolidated basis unless explicitly identified as company-only segment disclosure.
Results at a glance
- Consolidated net sales: PKR 8.280 billion, up 11.4% from PKR 7.435 billion.
- Gross profit: PKR 4.421 billion, up 29.6%; gross margin expanded to 53.4% from 45.9%.
- Operating profit: PKR 3.763 billion, up 21.9%; operating margin improved to 45.5% from 41.5%.
- Profit before tax and levies: PKR 3.199 billion, up 21.4%.
- Profit after tax: PKR 2.869 billion, up 44.1%; net margin rose to 34.6% from 26.8%.
- EPS: PKR 5.03 versus restated PKR 3.87 on the consolidated basis. EPS grew more slowly than PAT because the weighted-average share count was higher.
- No cash dividend, bonus, or rights entitlement was declared with the FY2026 result.
AlphaGen model scores
These are AlphaGen model outputs, not figures reported by GCIL and not investment recommendations.
- Alpha QoQ Score: 94.11
- TTM Performance Score: 95.41
- 3Y Business Perf Score: 99.22
- Sector Leadership Score: 72.8395
What improved
The largest operating change was the margin step-up. Net sales increased by PKR 844 million, while cost of sales declined by PKR 165 million, or 4.1%. Fuel and power—the largest disclosed production-cost line—fell to PKR 2.481 billion from PKR 2.610 billion. Gross profit therefore increased by just over PKR 1.0 billion, substantially faster than revenue.
The company-only segment note explains the mix. Industrial and medical gases generated PKR 8.140 billion of net sales, up 23.8%, and accounted for 98.3% of total net sales. Segment gross profit rose 30.8% to PKR 4.414 billion. By contrast, industrial-chemicals sales fell 83.7% to PKR 140 million and the segment moved to a loss after distribution and administrative costs. The stronger gas business more than offset the contraction in chemicals.
Actual gas production increased 16.1% to 70.7 million cubic metres. Management attributes growth to stronger market positioning, targeted investment, infrastructure and team expansion across healthcare, industrial, oil-and-gas and distributor channels. It also says timely capital spending helped it meet commitments in chemicals and refining and supported longer-term customer contracts. The filing does not quantify how much sales growth came from volume, price or customer mix, so the numerical conclusion should remain limited to higher output and a more gas-heavy revenue mix.
The capacity picture is more nuanced. Reported efficiency declined to 47% from 57%, even as output rose, because available capacity expanded materially. GCIL attributes under-utilisation to abnormal shutdowns and plant maintenance. That suggests capacity is available for future growth, but it also raises the execution question of whether the company can improve uptime and convert installed capacity into billable volume.
Operating leverage remained positive despite a sharp increase in selling costs. Operating profit rose 21.9%, and the operating margin gained roughly 3.9 percentage points. Other income also increased to PKR 501 million from PKR 394 million, supported by returns on advances to associated companies and PKR 123 million of management and resource-allocation charges to the GHG project company. Those items are legitimate reported income, but they are less directly tied to core gas production than product margins.
What weakened / needs attention
Distribution cost jumped to PKR 601 million from PKR 205 million. Transportation expense rose to PKR 359 million from PKR 68 million, while sales-promotion expense increased to PKR 81 million from PKR 23 million. Administrative expense increased 24.9% to PKR 359 million, partly because depreciation and employee costs were higher. These expenses did not erase the gross-margin gain, but their pace is too high to treat as incidental.
Finance cost rose 25.1% to PKR 567 million. The increase was driven by both long-term and short-term financing, even though disclosed borrowing rates were generally lower than in FY2025. Funded borrowings were approximately PKR 6.09 billion at year-end, up from roughly PKR 4.62 billion, against cash of PKR 1.09 billion. Equity also rose to PKR 11.66 billion, leaving balance-sheet leverage manageable, but the direction of travel matters.
The 44.1% PAT growth overstates the improvement in pre-tax earning power. PBT rose 21.4%, while the combined tax and levy charge fell to about PKR 330 million from PKR 644 million. That reduced the effective charge to roughly 10.3% of pre-tax profit from about 24.5%. The standalone tax reconciliation includes effects from exempt income and adjustments to unused tax losses. Investors should not assume the FY2026 tax rate repeats without further evidence.
Cash conversion was the clearest weakness. Consolidated operating cash flow fell to PKR 406 million from PKR 1.552 billion—only about 14% of reported PAT. Working capital absorbed PKR 3.109 billion, led by a PKR 1.314 billion increase in trade debts and a PKR 1.780 billion increase in loans and advances.
Trade debts rose 62.9% to PKR 3.391 billion. The company-only notes show PKR 2.178 billion of government receivables were past due or overdue but not impaired, almost double the prior-year level. One customer represented 18.18% of gross sales, broadly stable year on year. Management reports no recent default history for government balances, but collection timing is still economically important.
Loans and advances rose to PKR 3.431 billion, including PKR 2.970 billion due from related parties versus PKR 1.479 billion a year earlier. The largest balances were advances to Ghani Global Glass and Ghani ChemWorld, carrying mark-up and contractually repayable within three years. These advances generated income, but they also tied up cash that otherwise could have funded GCIL’s own expansion or reduced borrowing.
Despite the working-capital drain, liquidity improved on a point-in-time basis: cash rose 45.8%, and the current ratio increased to about 1.58 times from 1.29 times. That improvement was financed partly through PKR 1.209 billion of additional short-term borrowings. The balance sheet is therefore liquid, but not because earnings converted strongly into cash.
Capital allocation and future projects
GCIL invested PKR 606 million in fixed assets during FY2026 and arranged a PKR 400 million financing facility for a 6 MW solar project. It also invested PKR 200 million by year-end in GHG Emissions Mitigation Limited, its 49%-owned joint venture with Mari Energies. The venture is intended to recover vent and exhaust gas at Mari’s Sachal complex and convert recovered streams into LNG and industrial- or food-grade liquid CO₂.
After year-end, management described three additional gas-processing and commercialisation projects with Mari Energies, OGDCL and Maya Gas, with aggregate estimated cost above PKR 6 billion. GCIL expects to hold an 84% interest in a planned limited-liability partnership and proposes financing at a 66.5:33.5 debt-to-equity ratio. The board also recommended issuing 116.375 million Class B tracking shares at PKR 10 each—about 20.4%—to meet equity needs, subject to shareholder and regulatory approvals.
These projects could broaden GCIL beyond conventional industrial and medical gases, but they introduce construction, financing, partner and execution risk. The absence of an FY2026 dividend preserves capital, yet shareholders should weigh that choice alongside higher borrowings, related-party advances and the prospective share issuance.
What to monitor next
- Gas utilisation and uptime: output rose, but reported efficiency fell to 47%. Evidence of fewer shutdowns and better utilisation would support the next leg of operating growth.
- Receivable collections: the key test is whether government and large-customer balances convert into cash rather than continuing to expand faster than revenue.
- Related-party advances: watch repayments, accrued mark-up and whether advances to associated companies keep growing.
- Distribution discipline: transportation and promotion costs drove a major increase that should be measured against incremental sales and contract duration.
- Tax normalisation: future earnings should be assessed against a more sustainable tax burden, not automatically extrapolated from FY2026.
- Project financing: monitor final approvals, equity contribution, debt drawdown, timelines and commercial commissioning for the MARI joint venture and the three post-year-end gas projects.
- Capital returns: no FY2026 dividend was declared, so future distributions depend on cash collection and the funding demands of the project pipeline.
Bottom line
GCIL’s FY2026 result clears the bar for a strong operating year. The gas franchise expanded, gross margin improved sharply, production increased and consolidated PAT reached a record PKR 2.87 billion. The company also has visible expansion options in medical-gas pipelines and indigenous gas processing.
The quality discount is cash conversion. Receivables and related-party advances consumed most of the operating profit, while borrowings, finance cost and distribution expense all increased. A repeat of the income-statement growth—accompanied by much stronger collections—would materially improve the investment case. Without that cash follow-through, the headline profit growth will remain less compelling than it first appears.
Evidence limitations
The audited filing supports the full-year earnings, balance-sheet, cash-flow and segment analysis. It does not provide a quantified split between pricing, volume and mix, so no unsupported causal allocation is made. The annual cash-flow statement also does not establish discrete-quarter cash conversion; all cash-flow observations above refer to FY2026 as a whole.
Primary sources
PSX company page for GCIL announcements and financials
GCIL FY2026 financial results filed with PSX on September 28, 2026
GCIL Annual Report 2026 filed with PSX on October 8, 2026
GCIL corporate briefing presentation filed with PSX on October 23, 2026